Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Thor Medical

Less than 1K followers

TRMED

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor views

Thor Medical is a manufacturer and supplier of alpha particle emitters for cancer treatment. Radionuclide therapy (RNT) or radioligand therapy (RLT) using alpha particle emitters is a promising technology for cancer treatment. The main focus of the company is to refine the production technology, secure the customer base and necessary regulatory approvals for industrialization. Thor Medical is headquartered in Oslo.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
All
Press releases
ShowingAll content types

Regulatory press release22.09.2026 klo 08.30

Thor Medical ASA: Cancellation of Subsequent Offering

Thor Medical
Regulatory press release11.09.2026 klo 14.15

Thor Medical ASA: Completed Redelivery of Shares

Thor Medical
Regulatory press release10.09.2026 klo 11.20

Thor Medical ASA: Primary Insider Notification in Relation to Redelivery of Shares

Thor Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release10.09.2026 klo 11.15

Thor Medical ASA: Disclosure of Large Shareholding

Thor Medical
Regulatory press release10.09.2026 klo 11.09

Thor Medical ASA - Share Capital Increase in Relation to the Private Placement and the Retail Offering is Registered

Thor Medical
Regulatory press release04.09.2026 klo 08.00

Thor Medical ASA: Ex. Right to Participate in Subsequent Offering Today

Thor Medical
Regulatory press release04.09.2026 klo 00.34

Thor Medical ASA: Key Information Relating to Potential Subsequent Offering

Thor Medical
Regulatory press release04.09.2026 klo 00.26

Thor Medical ASA: Primary Insider Transaction

Thor Medical
Regulatory press release04.09.2026 klo 00.20

Thor Medical ASA: Disclosure of Large Shareholding

Thor Medical
Regulatory press release04.09.2026 klo 00.17

Thor Medical ASA: Private Placement and Retail Offering Successfully Completed

Thor Medical
Regulatory press release03.09.2026 klo 17.30

Thor Medical ASA: Contemplated Private Placement and Retail Offering

Thor Medical
Regulatory press release28.08.2026 klo 08.00

Thor Medical ASA: First Half 2026 Results - AlphaOne Operational, Entering Commercial Ramp-Up

Thor Medical
Regulatory press release25.08.2026 klo 08.00

Thor Medical ASA: Strengthening Executive Management Following AlphaOne Start-Up

Thor Medical
Regulatory press release19.08.2026 klo 08.00

TRMED: Thor Medical's AlphaOne Facility to be Officially Opened by Norwegian Prime Minister Jonas Gahr Støre

Thor Medical
Regulatory press release19.08.2026 klo 08.00

Thor Medical ASA: Invitation to Presentation of Half-Year 2026 Results

Thor Medical
Regulatory press release05.08.2026 klo 08.00

Thor Medical ASA: First Customer Delivery Completed from AlphaOne

Thor Medical
Regulatory press release31.07.2026 klo 08.00

Thor Medical ASA: AlphaOne Starts Commercial Production

Thor Medical
Regulatory press release29.05.2026 klo 08.00

TRMED: Thor Medical Enters Partnership Agreement with Minerva Imaging to Support Availability of Lead-212 in Europe

Thor Medical
Regulatory press release28.05.2026 klo 08.00

TRMED: Thor Medical Enters Partnership with Eckert & Ziegler to Enable Access of Lead-212 for the Pharmaceutical Industry

Thor Medical
Regulatory press release08.05.2026 klo 16.51

Thor Medical ASA: New share capital registered

Thor Medical